LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 39 filers reported holding LUMOS PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,393 | -22.5% | 15,564 | -22.5% | 0.00% | – |
| Q2 2023 | $66,328 | -2.6% | 20,089 | 0.0% | 0.00% | – |
| Q1 2023 | $68,081 | +90674.7% | 20,089 | -3.1% | 0.00% | – |
| Q4 2022 | $75 | -100.0% | 20,731 | 0.0% | 0.00% | – |
| Q3 2022 | $184,000 | +15.0% | 20,731 | 0.0% | 0.00% | – |
| Q2 2022 | $160,000 | -18.4% | 20,731 | 0.0% | 0.00% | – |
| Q1 2022 | $196,000 | +36.1% | 20,731 | 0.0% | 0.00% | – |
| Q4 2021 | $144,000 | -27.6% | 20,731 | -1.1% | 0.00% | – |
| Q3 2021 | $199,000 | -49.2% | 20,953 | -46.8% | 0.00% | – |
| Q2 2021 | $392,000 | -19.2% | 39,405 | -5.0% | 0.00% | – |
| Q1 2021 | $485,000 | -68.8% | 41,459 | -4.8% | 0.00% | -100.0% |
| Q4 2020 | $1,555,000 | +157.0% | 43,548 | -0.5% | 0.00% | – |
| Q3 2020 | $605,000 | -10.8% | 43,763 | +6.5% | 0.00% | – |
| Q2 2020 | $678,000 | +131.4% | 41,095 | +19.1% | 0.00% | – |
| Q1 2020 | $293,000 | – | 34,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acuitas Investments, LLC | 125,242 | $413,299 | 0.24% |
| Lion Point Capital, LP | 90,794 | $299,620 | 0.13% |
| Greenwich Wealth Management LLC | 76,341 | $252 | 0.03% |
| Wealth Advisors of Iowa, LLC | 11,699 | $38,606 | 0.03% |
| Marquette Asset Management, LLC | 25,760 | $85,008 | 0.02% |
| Key FInancial Inc | 10,927 | $36,059 | 0.01% |
| Paladin Advisory Group, LLC | 4,387 | $14,477 | 0.01% |
| Blackstone Inc. | 468,145 | $1,544,879 | 0.01% |
| Leucadia National | 120,651 | $398,148 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $157,222 | 0.00% |